As the clinical manifestations of NMOSD disease are comparable to those of MS, NMOSD has been misdiagnosed as a type of MS for many years until the identification of an anti NMO antibody known as anti-aquaporin (AQP4) in 2004 [3, 4]. The gene discussed is AQP4; the disease is myeloid sarcoma.